Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0234741784037559 0.039906103286385 0.0305164319248826 0.0281690140845071
Stock impact report

Paratek Announces FDA Advisory Committee Date for Omadacycline

Paratek Pharmaceuticals, Inc. (PRTK) 
Last paratek pharmaceuticals, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.paratekpharma.com
Company Research Source: GlobeNewswire
BOSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today announced that a meeting of the Antimicrobial Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has been scheduled for August 8, 2018 to review the Company's New Drug Applications (NDAs) for once-daily, oral and intravenous omadacycline. Omadacycline is under review for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).  The FDA accepted Paratek’s NDA for priority review in April 2018.  In the NDA acceptance letter, the FDA noted that it was planning to hold an advisory committee meeting. The target action date under the Prescription Drug User Fee Act (PDUFA) is early October 2018. About Paratek Pharmaceuticals, Inc. Paratek Pharmaceuticals, Inc. is a biopha Show less Read more
Impact Snapshot
Event Time:
PRTK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PRTK alerts
Opt-in for
PRTK alerts

from News Quantified
Opt-in for
PRTK alerts

from News Quantified